A bibliometric analysis from 2004 to 2024 reveals research hotspots and trends in the immunotherapy for vasculitis

Ruijuan Li,Ran Zhang,Yuheng Jia,Zhongbiao Nie
DOI: https://doi.org/10.1080/21645515.2024.2407206
2024-09-27
Human Vaccines & Immunotherapeutics
Abstract:Using bibliometric analysis, this study attempted to provide an overview of the current state of research and key findings regarding the immunotherapy for vasculitis in general. We gathered the literature from the Web of Science (WOS) database covering the last 20 years (2004–2024) pertaining to the immunotherapy for vasculitis, and we used Citespace to evaluate the mapping of knowledge. The findings demonstrated that there were 572 articles concerning the immunotherapy for vasculitis, with a faster growth after 2018. The USA, Assistance Publique Hopitaux Paris, and Cornelia M are the nation, organization, and writer with the highest number of publications. Daxini A (2018) is the most frequently mentioned reference as well (26). Prominent universities and developed nations form the finest alliances for research on immunotherapy for vasculitis researches. Immune checkpoint inhibitors, Wegener's granulomatosis, and systemic lupus erythematosus are Three research hotspots in this field.
immunology,biotechnology & applied microbiology
What problem does this paper attempt to address?